EyeID.va,baseline_va,baseline_va_category,one_year_va,X1,PatientID,Eye,EthnicCode,Gender,ageAtFirstTreatment,BaselineVA,bilateral,Group,VA_change_bl,one_year_va_category,change_va_one_year,stable_va_one_year,gain_2_lines_one_year,lost_3_lines_one_year,va_worse_6_60,va_worse_6_24,va_6_24_to_less_6_60,va_better_6_12,year_tx_initiation,baseline_va_category_meta_analysis,one_year_va_category_meta_analysis,baseline_va_category_meta_analysis_NICE,one_year_va_category_meta_analysis_NICE
1,75,1,79,21,1,R,Z,M,71,4/11/2017,0,Eylea,4,1,4,1,0,0,0,0,0,1,2017,1,1,1,1
2,60,2,75,52,2,R,Z,F,71,7/4/2012,0,Lucentis,15,1,15,1,1,0,0,0,0,1,2013,2,1,2,1
3,70,2,50,110,3,R,Z,F,70,11/6/2014,0,Eylea,-20,3,-20,0,0,1,0,1,1,0,2015,1,2,1,2
4,63,2,41,208,4,R,Z,F,74,10/20/2010,0,Lucentis,-22,3,-22,0,0,1,0,1,1,0,2011,2,3,2,3
5,36,3,31,277,5,R,A,F,79,5/22/2009,1,Lucentis,-5,4,-5,1,0,0,1,1,0,0,2009,3,4,3,4
6,70,2,85,397,6,R,A,M,79,3/21/2016,1,Eylea,15,1,15,1,1,0,0,0,0,1,2016,1,1,1,1
